- Home
- » Tags
- » Balsalazide
Top View
- FDA Listing of Established Pharmacologic Class Text Phrases January 2021
- Therapeutic Class Overview Inflammatory Bowel Disease Agents
- Ulcerative Colitis
- Aminosalicylates
- Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
- Ulcerative Colitis Agents Therapeutic Class Review (TCR)
- Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
- COLAZAL? (Balsalazide Disodium) Capsules
- Brand Generic Guide
- Medicaid List of Covered Drugs (Formulary)
- Medical Terms Used in Ibd
- ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
- Molecular Similarity and Diversity Analysis of Bioactive Small Molecules Using Chemoinformatics Approaches
- 2019 Medicaid Preapproval Criteria
- Therapeutic Class Overview Ulcerative Colitis Agents
- Gpi Drug Classification Report
- 5-ASA) (Mesalamine, Balsalazide, Sulfasalazine
- Additional Therapeutic Classes with Clinical Criteria
- Balsalazide Disodium) Capsules COLAZAL Capsules Or Balsalazide Metabolites
- Neemmc Guidelines for Tablet Crushing and Administration Via Enteral Feeding Tubes
- Preferred Drug List (PDL)
- California 3 Tier Drug List
- Understanding IBD Medications and Side Effects 187767 WF1 Form:Layout 1 11/13/09 7:27 PM Page 2 187767 WF1 CVR R1.Qxp:Layout 1 11/19/09 4:51 PM Page B
- Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: a Systematic Review and Meta-Analysis
- Wo 2007/044693 A2
- Provider Manual
- Medication Coverage Policy
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Draft Scope Post Referral PDF 198 KB
- Ulcerative Colitis
- (12) Patent Application Publication (10) Pub. No.: US 2015/0110838 A1 Agrawal (43) Pub
- FEP 5 Tier Managed Rx Drug Formulary (807) Basic Option
- Pharmaceutical Appendix to the Tariff Schedule 2
- Inflammatory Bowel Agents Class Update
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Budesonide (UCERIS)
- [Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
- 2018 Drug List This Document Contains Information NTENNIALCARE About the Drugs We Cover in This Plan
- Handbook of Drug Administration Via Enteral Feeding Tubes Via Enteral Feeding Tubes
- Guidelines for the Administration of Drugs Through Enteral Feeding Tubes
- Drugs/Biologics Not Covered Unless Approved Under Medical Necessity Review Employer Group Plans: Standard, Performance, Or Legacy Prescription Drug List
- Final Scope PDF 184 KB
- Proximal Pathway Enrichment Analysis for Targeting Comorbid Diseases Via Network Endopharmacology
- Preferred Drug List
- Supplementary Table 1 As Described in the Methods Section, for Every Medication, Odds Ratios
- Resolution Ap (2000) 1
- Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
- Antibiotic Use and Resistance in Food Animals Current Policy and Recommendations © Center for Disease Dynamics, Economics & Policy, 2016
- Oregon Medicaid Preferred Drug List, January 1, 2021.Pdf
- Budesonide (Uceris®)